Danaher Corporation (DHR) NYSE
178.28
-0.7(-0.39%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
178.28
-0.7(-0.39%)
Currency In USD
Address
2200 Pennsylvania Avenue, NW
Washington, DC 20037-1701
United States of America (the)
Phone
202 828 0850
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
61000
First IPO Date
December 29, 1978
| Name | Title | Pay | Year Born |
| Christopher Paul Riley | Executive Vice President of Biotechnology Group & Chief Executive Officer of Cytiva | 2.54M | 1974 |
| Rainer Blair | President, Chief Executive Officer & Director | 6.12M | 1964 |
| Georgeann F. Couchara | Senior Vice President of Human Resources | 1.94M | 1977 |
| Brian W. Ellis | Executive Officer | 2.04M | 1967 |
| Jose-Carlos Gutierrez-Ramos | Senior Vice President & Chief Science Officer | 2.52M | 1962 |
| Julie Sawyer Montgomery | Executive Vice President of Diagnostics Platform | 2.58M | 1973 |
| Matthew E. Gugino | Chief Financial Officer & Executive Vice President | 2.7M | 1983 |
| Matthew R. McGrew | Executive Vice President | 3.17M | 1972 |
| Martin Stumpe | Chief Technology & AI Officer | 0 | N/A |
| Kornelija Zgonc | Vice President of R&D at Hach | 0 | N/A |
| Christopher Bouda | Vice President & Chief Accounting Officer | 0 | N/A |
| Frank T. McFaden | Vice President and Treasurer | 0 | N/A |
| John Bedford | Vice President of Investor Relations | 0 | N/A |
| Mitchell Rales | Co-Founder & Director | 0 | 1957 |
| R. Bradley Gray | Senior Vice President of Strategic Development | 0 | 1977 |
| Steven Rales | Co-Founder & Chairman | 0 | 1951 |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.